JENNIFER FIFE: Open Payments
NPI 1235627910 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,382 in 64 payments from 13 companies in 2025. Trend: 2023 $297 · 2024 $1,397 · 2025 $1,382
Food & beverage: $1,382
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $379 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $257 |
| Alnylam Pharmaceuticals Inc. | 8 | $198 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $116 |
| Merck Sharp & Dohme LLC | 5 | $97 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| BridgeBio Pharma, Inc. | 2 | $34 |
| Abbott Laboratories | 1 | $21 |
Products named: CAMZYOS, JARDIANCE, FARXIGA, AMVUTTRA, ONPATTRO, WINREVAIR, Kerendia, Adempas.
Industry payments across KY — which companies pay providers there.
